T cell-based HIV vaccine candidate demonstrates positive results
Monday, November 10, 2008 - 01:08
in Health & Medicine
The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.
Read the whole article on Biology News Net
More from Biology News Net
Related
- T cell-based HIV vaccine candidate demonstrates positive resultsSun, 9 Nov 2008, 14:15:18 EST
- India continues to progress in AIDS vaccine development effortsMon, 18 Aug 2008, 0:22:02 EDT
- Results of landmark study of HIV vaccine published in the LancetWed, 12 Nov 2008, 18:42:45 EST
- IAVI statement in response to NIAID decision not to move forward with PAVE 100 HIV Vaccine TrialThu, 17 Jul 2008, 12:14:46 EDT
- Outfoxing pox: Developing a new class of vaccine candidatesThu, 15 Oct 2009, 11:16:28 EDT